Friday, September 2, 2022

Agomelatine and Ramelteon prevent SARS-CoV-2 entry in the brain thereby reducing virus-induced damage of small cerebral vessels immune cell infiltration and brain inflammation

Agomelatine and ramelteon prevent SARS-CoV-2 entry in the brain thereby reducing virus-induced damage of small cerebral vessels immune cell infiltration and brain inflammation molecular modeling analysis complemented by experimental studies in cells show that SARS-CoV-2 entry into endothelial cells is prevented by melatonin binding to allosteric-binding site on human Angiotensin converting enzyme to ACE 2 that's interfering with ACE 2 function as an entry receptor for SARS-CoV-2 are findings open new perspectives for the repurposing of melatonin generic drugs and it's clinically used analogs in the prevention of brain infection by SARS-CoV-2 and Covid-19 related long-term neurological symptoms. 

Lumbrokinase for large clots, nattokinase and serrapeptase for micro and clot digestion

O, Democrats, we hardly knew ye . . . that's not true. We've known all along that you're foot soldiers for international communism

Same gas as before but now liquified and routed via China at much higher price and transport costs . . .

SEE DR. DAVID SINCLAIR FOR MORE ON NAD+ & NMN

Here is a brief video explaining the benefits of NAD.

 
And another on NMN.